市值: $3.2952T -0.400%
成交额(24h): $109.7451B -17.560%
  • 市值: $3.2952T -0.400%
  • 成交额(24h): $109.7451B -17.560%
  • 恐惧与贪婪指数:
  • 市值: $3.2952T -0.400%
加密货币
话题
百科
资讯
加密话题
视频
热门新闻
加密货币
话题
百科
资讯
加密话题
视频
bitcoin
bitcoin

$104121.971223 USD

1.13%

ethereum
ethereum

$2574.912516 USD

-0.45%

tether
tether

$1.000157 USD

0.00%

xrp
xrp

$2.397504 USD

-5.45%

bnb
bnb

$658.072670 USD

1.46%

solana
solana

$172.284427 USD

-1.92%

usd-coin
usd-coin

$0.999942 USD

0.01%

dogecoin
dogecoin

$0.225761 USD

-3.34%

cardano
cardano

$0.778900 USD

-2.02%

tron
tron

$0.275199 USD

0.64%

sui
sui

$3.911718 USD

0.98%

chainlink
chainlink

$16.224989 USD

-3.65%

avalanche
avalanche

$23.835825 USD

-2.83%

stellar
stellar

$0.295436 USD

-2.70%

hyperliquid
hyperliquid

$26.948906 USD

8.20%

加密货币新闻

巴塞尔医学集团(NASDAQ:BMGL)已进入独家谈判,以10亿美元收购比特币(BTC)

2025/05/16 23:36

此举将重塑公司的财政部储备,同时继续关注整个亚洲的医疗保健。

Basel Medical Group Ltd (Nasdaq: BMGL) is in the midst of a substantial financial transformation. As disclosed in a recent filing with the U.S. Securities and Exchange Commission (SEC), the company has entered into exclusive negotiations for a $1 billion acquisition of Bitcoin (BTC) from a private seller.

巴塞尔医学集团有限公司(NASDAQ:BMGL)处于实质性的财务转型之中。正如最近提交给美国证券交易委员会(SEC)的一份文件中所披露的那样,该公司已通过从私人卖方从10亿美元收购比特币(BTC)进行独家谈判。

This deal, still subject to standard closing conditions and regulatory approvals, is being structured as a share-swap transaction with institutional investors and high-net-worth individuals from the cryptocurrency sector, who will be converting their BMGL shares into preferred shares.

这项协议仍然受到标准结束条件和监管部门的批准,正在与来自加密货币行业的机构投资者和高净值个人的股票交易结构,他们将将其BMGL股份转换为首选股票。

Upon completion, which is anticipated within the current financial quarter, the company will be incrementally funded with $1 billion in capital, positioning BMGL among the most financially flexible medical service providers in the Asia-Pacific region.

预计将在本财政季度内完成后,该公司将获得10亿美元的资本资金,将BMGL定位为亚太地区最灵活的医疗服务提供商。

The company's shares rose by 5.4% in premarket trading on Wednesday.

该公司的股票在周三的上市交易中增长了5.4%。

Basel Medical is currently seeking to expand its presence in emerging Asian healthcare markets, and this transaction is expected to diversify the company's balance sheet and provide it with greater access to capital for future acquisitions.

巴塞尔医疗公司目前正在寻求扩大其在新兴的亚洲医疗保健市场中的影响力,预计该交易将使公司的资产负债表多样化,并为其提供更多的资本供未来收购。

"This $1 billion financial transformation will give us the capacity to execute our Asia growth strategy while maintaining conservative financial management," said Dr. Darren Chhoa, Chief Executive Officer of BMGL.

BMGL首席执行官Darren Chhoa博士说:“这种10亿美元的财务转型将使我们能够在维持保守的财务管理的同时执行亚洲增长战略。”

"We are also cognizant of the importance of aligning our actions with our values. This move supports our mission to become a top-tier healthcare platform in the region, offering high-quality medical services with integrity and efficiency," he added.

他补充说:“我们还认识到使我们的行动与价值观保持一致的重要性。此举支持我们成为该地区顶级医疗平台的使命,提供具有正直和效率的高质量医疗服务。”

The company is working closely with a group of crypto-focused investors to finalize the terms of the transaction, which will be structured to ensure optimal tax treatment for all parties involved.

该公司正在与一群以加密货币为中心的投资者进行紧密合作,以最终确定交易条款,这些条款将是结构的,以确保所有有关方面的最佳税收待遇。

The transaction is expected to close in the third quarter of 2023, subject to regulatory approvals, including those from the relevant authorities in Singapore and the United States, as well as other standard closing conditions.

预计该交易将在2023年第三季度完成,但要获得法规批准,包括来自新加坡和美国的相关当局以及其他标准关闭条件的交易。

免责声明:info@kdj.com

所提供的信息并非交易建议。根据本文提供的信息进行的任何投资,kdj.com不承担任何责任。加密货币具有高波动性,强烈建议您深入研究后,谨慎投资!

如您认为本网站上使用的内容侵犯了您的版权,请立即联系我们(info@kdj.com),我们将及时删除。

2025年05月17日 发表的其他文章